Current Articles

Obesity Drug Has Little Effect On Heart In Teens When the weight-loss drug sibutramine, marketed under the brand names Meridia or Reductil, is used to treat obesity in adolescents, it is associated with small decreases in blood pressure and pulse rate, according to a new study.
Erythropoietin may increase risk of thromboembolism Treatment with recombinant human erythropoietin reduces the need for transfusion among patients with cancer, but it may also increase the risk of thromboembolic events or tumor progression, results of a meta-analysis suggest.
WHO chief Lee dies after blood clot surgery World Health Organization chief Lee Jong-wook of South Korea, his country's top international official, died on Monday after surgery to remove a blood clot from the brain, the United Nations agency said.
More join US Medicare drug plan Voluntary enrollment for the new Medicare drug benefit is growing faster than expected, U.S. health officials said on Tuesday even as about 20 states reported problems with patients receiving their medication.
Drug makers object to U.S. plan for early warnings Plans by U.S. regulators to release preliminary information about potential drug side effects could lead to unnecessary confusion and "irrational fears" about medicines, drug makers said on Monday.
Guidant to set up panel on implantable devices Cardiovascular device company Guidant Corp. said on Wednesday it planned to create an independent panel to devise guidelines about when to give information to doctors and patients about risks related to implantable medical devices.
Ximelagatran monitoring not needed in deep vein thrombosis When given to patients with acute deep vein thrombosis, the pharmacokinetics of melagatran, the active form of ximelagatran, are predictable and the exposure-response curves suggest that individualized dosing and monitoring of the parent drug is not needed.
Stroke risk tripled when aspirin use discontinued in stroke survivors Risk of a recurrent stroke is tripled within the month if aspirin therapy is discontinued, Swiss researchers reported here at the American Stroke Association's International Stroke Conference 2005.
 
Copyright Reuters 2006
Society for Vascular Surgery - 633 N. St. Clair, 24th Floor; Chicago, IL 60611; Phone: 312-334-2300 or 800-258-7188; Fax: 312-334-2320; Email: vascular@vascularsociety.org
 © 2008 VascularWeb. All rights reserved. Use of the VascularWeb site constitutes acceptance of all of the policies, rules and regulations for the site.